Avista Healthcare Partners GP, Ltd. - Aug 15, 2023 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
10%+ Owner
Signature
Avista Healthcare Partners GP, Ltd. By: /s/ Ben Silbert, Chief Administrative Officer and General Counsel
Stock symbol
RVLP
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4
Date filed
8/17/2023, 05:04 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Other -23.7M -100% 0 Aug 15, 2023 By Avista Capital investment fund F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Avista Healthcare Partners GP, Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents a pro rata in-kind distribution of Ordinary Shares of the Issuer to partners for no consideration and includes subsequent distributions by such partners to their partners and members.
F2 Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.